| RS886041227 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Autosomal dominant hypophosphatemic rickets |
| RS886041228 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS886041231 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome |
| RS886041232 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS886041233 |
RHO
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS886041234 |
RMRP
|
Health Risk |
Pathogenic |
— |
| RS886041235 |
RS1
|
Health Risk |
Pathogenic |
Juvenile retinoschisis, Juvenile retinoschisis |
| RS886041236 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS886041237 |
SDHD
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma and paraganglioma |
| RS886041238 |
SHANK3
|
Health Risk |
Pathogenic |
SHANK3-related disorder, Phelan-McDermid syndrome |
| RS886041239 |
SMC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Cornelia de Lange syndrome 3 |
| RS886041240 |
SNAP29
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 2, CEDNIK syndrome |
| RS886041241 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome, RASopathy |
| RS886041242 |
SOX9
|
Health Risk |
Conflicting classifications of pathogenicity |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS886041244 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS886041245 |
SPTBN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 5, Spinocerebellar ataxia type 5 |
| RS886041246 |
STXBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS886041247 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Holt-Oram syndrome |
| RS886041248 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS886041249 |
TGIF1
|
Health Risk |
Likely pathogenic |
— |
| RS886041250 |
TGM1
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 1, Lamellar ichthyosis |
| RS886041251 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, Ectrodactyly |
| RS886041252 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS886041253 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, VHL-related disorder |
| RS886041259 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS886041262 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS886041264 |
BRAF
|
Health Risk |
Likely pathogenic |
— |
| RS886041265 |
ACTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS886041266 |
ACTB
|
Health Risk |
Likely pathogenic |
— |
| RS886041267 |
ACTB
|
Health Risk |
Pathogenic |
— |
| RS886041268 |
ACTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS886041269 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041270 |
ACTB
|
Health Risk |
Conflicting classifications of pathogenicity |
ACTB-related BAFopathy, Baraitser-Winter syndrome 1 |
| RS886041272 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS886041273 |
MMP21
|
Health Risk |
Pathogenic/Likely pathogenic |
Heterotaxy, visceral |
| RS886041274 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS886041275 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS886041276 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS886041277 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS886041278 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS886041279 |
CACNA1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS886041280 |
ACTG1
|
Health Risk |
Likely pathogenic |
— |
| RS886041281 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, CTNNB1-related disorder |
| RS886041282 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS886041283 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS886041284 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS886041285 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome |
| RS886041286 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS886041287 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886041288 |
HPRT1
|
Health Risk |
Pathogenic |
— |
| RS886041289 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS886041290 |
MYCN
|
Health Risk |
Pathogenic |
— |
| RS886041291 |
DYRK1A
|
Health Risk |
Pathogenic |
Global developmental delay, DYRK1A-related intellectual disability syndrome |
| RS886041292 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS886041293 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS886041294 |
MC2R
|
Health Risk |
Pathogenic |
— |
| RS886041295 |
GRIN2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS886041296 |
PHEX
|
Health Risk |
Pathogenic |
Hypophosphatemic rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041297 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS886041298 |
HPRT1
|
Health Risk |
Pathogenic |
— |
| RS886041299 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886041300 |
KCNH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Severe intellectual disability |
| RS886041302 |
CRPPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS886041303 |
CAPN5
|
Health Risk |
Pathogenic |
Proliferative vitreoretinopathy, Inborn genetic diseases |
| RS886041304 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS886041305 |
ACTB
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Baraitser-Winter syndrome 1 |
| RS886041306 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS886041307 |
PROKR2
|
Health Risk |
Pathogenic |
— |
| RS886041308 |
GRIN2A
|
Health Risk |
Pathogenic |
— |
| RS886041309 |
ACTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Baraitser-Winter syndrome 1 |
| RS886041310 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiofaciocutaneous syndrome 4, RASopathy |
| RS886041312 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS886041314 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 6A (Zellweger), Peroxisome biogenesis disorder 6B |
| RS886041315 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS886041316 |
EXOSC3
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1B, Pontoneocerebellar hypoplasia |
| RS886041317 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS886041318 |
OPA1
|
Health Risk |
Pathogenic |
OPA1-related disorder, Autosomal dominant optic atrophy classic form |
| RS886041319 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS886041320 |
MYBPC3
|
Health Risk |
Pathogenic |
— |
| RS886041321 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS886041322 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular cardiomyopathy |
| RS886041323 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, VPS13B-related disorder |
| RS886041324 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS886041325 |
ENG
|
Health Risk |
Pathogenic |
Hereditary hemorrhagic telangiectasia, Cardiovascular phenotype |
| RS886041326 |
ENG
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary hemorrhagic telangiectasia |
| RS886041327 |
PRRT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS886041328 |
RPS6KA3
|
Health Risk |
Pathogenic |
— |
| RS886041329 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS886041330 |
RPS6KA3
|
Health Risk |
Pathogenic |
— |
| RS886041331 |
RPS6KA3
|
Health Risk |
Pathogenic |
— |
| RS886041332 |
PTEN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS886041333 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS886041334 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS886041335 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886041336 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS886041337 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS886041338 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS886041339 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS886041340 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS886041341 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |